Första AP-fonden’s Jazz Pharmaceuticals JAZZ Stock Holding History

Första AP-fonden’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,100	Closed	-$258K	–	575
2023 Q4	$258K	Sell	2,100 -19,900	-90%	-$2.48M	﹤0.01%	564
2023 Q3	$2.85M	Buy	22,000 +2,900	+15%	+$386K	0.03%	472
2023 Q2	$2.37M	Buy	+19,100	New	+$2.57M	0.03%	503
2022 Q3	–	Sell	-2,000	Closed	-$312K	–	603
2022 Q2	$312K	Sell	2,000 -100	-5%	-$15.4K	﹤0.01%	551
2022 Q1	$327K	Buy	+2,100	New	+$305K	﹤0.01%	550
2021 Q4	–	Sell	-13,300	Closed	-$1.73M	–	573
2021 Q3	$1.73M	Buy	+13,300	New	+$2.01M	0.02%	506
2021 Q1	–	Sell	-1,300	Closed	-$215K	–	543
2020 Q4	$215K	Buy	+1,300	New	+$194K	﹤0.01%	514

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Första AP-fonden's JAZZ Position: Q1 2024 in Review

Första AP-fonden sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 2,100 shares — an estimated $258K sold.

Första AP-fonden first reported a position in JAZZ in Q4 2020 and held it in 7 quarters. The position peaked at $2.85M in Q3 2023. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

Första AP-fonden reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Första AP-fonden sold 2,100 Jazz Pharmaceuticals shares in Q1 2024, an estimated $258K.
Första AP-fonden first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Första AP-fonden's Jazz Pharmaceuticals position peaked at $2.85M in Q3 2023.
481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Första AP-fonden's 13F filing for Q1 2024, filed 7 May 2024.